News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,017 Results
Type
Article (41591)
Company Profile (463)
Press Release (658963)
Section
Business (208392)
Career Advice (2002)
Deals (35941)
Drug Delivery (92)
Drug Development (83301)
Employer Resources (169)
FDA (16325)
Job Trends (15043)
News (352079)
Policy (32978)
Tag
Academia (2619)
Alliances (50599)
Alzheimer's disease (1273)
Approvals (16250)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11732)
Biotechnology (349)
Breast cancer (123)
Cancer (1111)
Cardiovascular disease (102)
Career advice (1671)
Cell therapy (247)
Clinical research (65992)
Collaboration (405)
Compensation (199)
COVID-19 (2590)
C-suite (100)
Data (1138)
Diabetes (156)
Diagnostics (6197)
Earnings (86042)
Employer resources (147)
Events (112903)
Executive appointments (313)
FDA (16865)
Funding (362)
Gene therapy (191)
GLP-1 (610)
Government (4408)
Healthcare (18995)
Infectious disease (2674)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16571)
Job creations (3694)
Job search strategy (1428)
Layoffs (439)
Legal (7928)
Lung cancer (174)
Manufacturing (181)
Medical device (13322)
Medtech (13327)
Mergers & acquisitions (19430)
Metabolic disorders (423)
Neuroscience (1564)
NextGen Class of 2024 (6733)
Non-profit (4532)
Northern California (1494)
Obesity (242)
Opinion (198)
Patents (102)
People (57620)
Phase I (20678)
Phase II (29132)
Phase III (21545)
Pipeline (458)
Postmarket research (2590)
Preclinical (8877)
Radiopharmaceuticals (251)
Rare diseases (233)
Real estate (5998)
Regulatory (21955)
Research institute (2403)
Resumes & cover letters (351)
Southern California (1323)
Startups (3746)
United States (13802)
Vaccines (565)
Weight loss (182)
Date
Today (137)
Last 7 days (814)
Last 30 days (3829)
Last 365 days (36674)
2024 (33592)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (200)
Asia (38508)
Australia (6402)
California (3407)
Canada (1289)
China (252)
Colorado (146)
Connecticut (160)
Europe (83982)
Florida (458)
Georgia (116)
Illinois (351)
Indiana (198)
Kansas (99)
Maryland (588)
Massachusetts (2711)
Michigan (159)
Minnesota (277)
New Jersey (965)
New York (965)
North Carolina (754)
Northern California (1494)
Ohio (140)
Pennsylvania (848)
South America (1105)
Southern California (1323)
Texas (473)
Utah (92)
Washington State (371)
701,017 Results for "poseida therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
November 12, 2024
·
1 min read
Biotech Beach
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
Poseida Therapeutics, Inc. announced that its virtual Annual Meeting of Stockholders will be held on Monday, June 17, 2024 at 1:00 p.m. PT.
June 3, 2024
·
2 min read
Press Releases
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
November 8, 2024
·
17 min read
Press Releases
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline
November 15, 2024
·
13 min read
Business
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, today announced updates and financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
14 min read
Business
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, “Xyphos”) and Poseida have entered into a research collaboration and license agreement to develop novel convertibleCAR® programs by combining the innovative cell therapy platforms from each of the companies.
May 1, 2024
·
8 min read
Business
Poseida Therapeutics to Present at Upcoming Investor Conferences
August 29, 2024
·
1 min read
Press Releases
Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
November 5, 2024
·
9 min read
Press Releases
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche
October 17, 2024
·
7 min read
Business
Poseida Therapeutics Named to Newsweek’s List of the Top 200 America’s Most Loved Workplaces for 2024
October 3, 2024
·
4 min read
1 of 70,102
Next
